TW307682B - - Google Patents

Download PDF

Info

Publication number
TW307682B
TW307682B TW083103796A TW83103796A TW307682B TW 307682 B TW307682 B TW 307682B TW 083103796 A TW083103796 A TW 083103796A TW 83103796 A TW83103796 A TW 83103796A TW 307682 B TW307682 B TW 307682B
Authority
TW
Taiwan
Prior art keywords
acid
polyoxyethylene
oil
hardened
hemp oil
Prior art date
Application number
TW083103796A
Other languages
Chinese (zh)
Original Assignee
Sansyou Pharmaceutics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sansyou Pharmaceutics Co Ltd filed Critical Sansyou Pharmaceutics Co Ltd
Application granted granted Critical
Publication of TW307682B publication Critical patent/TW307682B/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/31Hydrocarbons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55Phosphorus compounds
    • A61K8/553Phospholipids, e.g. lecithin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Description

307682 五、發明説明(1 ) 本發明係在含有麴酸及/或其衍生物與紫外線吸收劑 之外用劑中添加至少一種選自烴類,脂質類,硬化或未硬 化油脂類所成群,以提高麴酸及/或其衍生物之製劑安定 性,使其具有持績性之藥。 皮虜外用劑之代表劑型有0/W型乳液,與W/0型 乳液,水或油份之組成比或物性雖各不相同,但均爲含有 界面活性劑而可成爲水相與油相安定地被乳化分散之均一 製劑。 至於本案申請人長年持績硏究之麴酸及其衍生物係眾 所周知具有各種優異特性,有用性高之藥物,該技術上成 果有例如被揭示於特開昭5 5 — 1 5 7 5 0 9號公報, 特開昭5 6-1 8 5 6 9號公報, 特開昭5 8-2 2 1 5 1號公報, 特開昭5 8 — 2 2 1 5 2號公報, 特開昭5 8 — 3 4 4 4 6號公報, 特開昭6 0 — 7 9 6 1號公報, 特開昭6 0 — 9 7 2 2號公報, 經濟部中央標隼局員工消費合作社印製 特開昭6 0 — 1 〇 〇 〇 5號公報, 特開昭6 0 — 1 3 7 2 5 3號公報, 特開昭6 1 — 1 〇 4 4 7號公報, 特開昭6 1 — 6 0 8 0 1號公報, 特開昭6 2 — 5 9 0 9號公報, 特開昭6 2 — 3 8 2 0號公報, 特開昭63—27322號公報, 83. 3.10,000 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家榇準(CNS ) A4規格(210X297公釐) 307682 五、發明説明(2 ) 特開平1 — 1 3 2 5 0 2號公報及 特公平5 — 3 0 4 2 2號公報等。 惟所知者,此麴酸及其衍生物(以下總稱此等僅稱「 麴酸」)係其本身很難確保其安定性之藥物。例如欲配合 麴酸於如上述之o/w型乳液或w/〇型乳液予以製劑時 ,處方設計必須爲相當高度之技術,所以針對開發木會破 壞使用感,並且可以耐於嚴厲條件之流通過程的製劑技術 ,乃成爲麴酸類製劑上當面課題。 配合麴酸於各種劑型時,多多少少均會使其被曝露於 成爲麴酸著色,分解之外來原因的紫外線。爲此有適當配 合紫外線吸收劑之提案,例如特開昭6 2 _ 1 0 8 8 0 4 號公報,特開昭6. 4 — 8 3 0 0 8號公報及特公平 4 — 4 6 9 2 4號公報等。 惟此等紫外線吸收劑,多數均有溶解性上之問題,常 會在製劑中析出,所以不但無法充分發揮紫外線吸收劑原 具有之效果,還會影響而降低麴酸之安定性。 爲解決此缺點,雖使用適當之溶解助劑,惟大量使用 經濟部中央標準局員工消費合作社印製 油性之助劑時,反而會產生粘連感,對使用感有不良影響 0 又,製劑配合有麴酸之外用劑時,在著色安定性,使 用感及皮虜之安全性上較適宜使用之界面活性劑雖有非離 子系者,惟此非離子系之界面活性劑。不但不具有如離子 系界面活性劑一樣强力之乳化性,而且常會受到極性高之 成份或P Η値之影響,而有降低乳化力之缺點,所以對於 83. 3.10,000 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家樣準(CNS ) Α4規格(210Χ297公釐) 經濟部中央標準局員工消費合作社印製 A 7 B7 五、發明説明(3 ) 常常需調整p Η値爲4〜5之麴酸類製劑而言,配合極性 高之紫外線吸收劑時,常會有經久後降低乳化安定性之問 題。 本發明係在含有麴酸及/或其衍生物與紫外線吸收劑 之外用劑中藉由添加至少一種選自烴類,脂質類,及硬化 或未硬化油脂類所成群,以提供無紫外線吸收劑之析出, 且可以改善麴酸類著色分解,經久仍具極佳安定性,並改 善其藥效持績性之製劑特性極佳的皮膺外用劑爲目的者。 依本發明可提供在含有麴酸及/或其衍生物與紫外線 吸收劑之外用劑中藉由添加至少一種選自烴類,脂質類及 硬化或未硬化油脂類所成群,得以成爲無紫外線吸收劑之 析出,且可以改善麴酸類因熱而著色分解,經久仍具極佳 安定性,並改善其藥效持續性之製劑特性極佳的皮虜外用 劑。 本發明'中做爲第1成份所用之麴酸(5 -氧基一2 — 氧甲基一?* —吡喃酮)可以使用5 —氧基一2 —氧甲基一 r -吡喃酮之純品,自可以生產麴酸之公知菌株培養所得 以麴酸爲主成份之醱酵液,該醱酵液之濃縮液,及自該醱 酵液萃取予以晶化之麴酸等。 麴酸衍生物可爲例如使用一種或組合二種以上特公昭 6 0 — 1 0 0 0 5號公報、特開平1-4 5 4 7 2號公報 、特公平3 — 7 4 2 2 9號公報、特開昭5 8 — 2 2 1 5 1號公報、特公昭5 8 — 2 2 1 5 2號公報等所揭示麴酸 之酯化物及麴酸之二位的-C H2〇H基上結合糖類之麴 本紙張尺度逋用中國國家揉準(CNS ) A4規格(210X297公釐) 83. 3.10,000 (請先閲讀背面之注意事項再填寫本頁) ---------訂------線《------ 307682 五、發明説明(4 ) 酸.衍生物等公知者。 ’ 對於製劑而言,麴酸及/或其衍生物之配合量係對全 部外用劑而言爲0. 001〜10重置%,較佳係0. 1 〜5重量%範圍。 本發明中做爲第2成份所用之紫外線吸收劑並不特別 限制,惟可以爲二苯甲酮系之2 —羥基一 4 —甲氧基二苯 甲酮,2 —羥基一 4 _甲氧基二苯甲酮磺酸,羥甲氧基二 苯甲酮磺酸鈉,二羥二甲氧基二苯甲酮等,柳酸系之柳酸 乙二醇,柳酸高1酯,柳酸苯酯等,尿刊酸及尿刊酸乙酯 ,肉挂酸系之對甲氧基肉桂酸2 —乙基己酯,甲氧*肉桂 酸辛酯等,對胺基苯甲酸系之對胺基苯甲酸甘油酯,對二 甲胺基苯甲酸2 —乙基己酯,二苯甲醯甲烷系之4 一第三 丁基一4 > —甲氧基二苯甲醯甲烷等或苯並三唑系之2 — (2 —羥基-5 -甲苯基)苯並三唑等較適宜,此等可單 獨或組合二種以上使用。又,其他還可適當組合具有紫外 線吸收能之公知動,植物萃取物予以使用。 經濟部中央標準局貝工消費合作社印製 此等紫外線吸收劑之配合量係因其種類之不同而異, 通常對全量外用劑而言配合0. 001〜10重量%,較 佳係0 . 1〜5重量%。 做爲本發明之第3成份所用之烴類可以適當地使用例 如α —烯類低聚物,流動異鏈烷烴,塑基料Plastibase, 曰本Squeeve公司製),聚異丁烯,聚丁烯等鏈烷烴系 烴類或烯系烴類,其中尤以碳數1 0以上之低極性者爲宜 83.3.10,000 (請先閲讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) A7 B7 307682 五、發明説明(5 ) 脂質類以磷脂質類爲最適宜,具體言有例如卵黃,大 豆,玉米等天然物萃取所得之磷脂醯膽鹸,磷脂醯肌醇, 磷脂醯乙醇胺,磷脂醯絲胺酸等甘油磷脂質,神經鞘磷脂 ,神經醯胺氨乙基磷酸等神經鞘磷脂質,神經鞘糖脂質, 二硬脂醯磷脂醯膽鹸,二棕櫚醯基磷脂醯膽鹸等合成磷脂 質類等。 硬化或未硬化油脂類有例如聚氧乙烯硬化箆麻油,三 異硬脂酸聚氧乙烯硬化箆麻油,異硬脂酸聚氧乙烯硬化箆 麻油,月桂酸聚氧乙烯硬化蓖麻油,聚氧乙烯硬化蓖麻油 ,聚氧乙烯山梨糖醇蜜蠟等聚合度爲4 0〜1 〇 〇左右之 完全硬化箆麻油爲較適宜,此等可以單獨或組合二種以上 使用。 此等發明之第3成份的配合量係因其種類而異,惟通 常對全量之外用劑爲〇 : ο 〇 1〜2 0重置%,較佳以 0. 1〜10重量%爲宜。 依公知之製造方法製造以上以第1〜第3成份群爲必 須成份之外用劑時,可得無紫外線吸收劑之析出,經久亦 具安定之乳化製劑。又,可以顯著改善本製劑中之麴酸類 的經久會著色,分解之缺點,除此外還可以提高其經皮吸 收能力,所以可提供持續地可發揮麴酸類之藥效的皮虜外 用劑。 上述本發明製劑當然亦不僅限於0/W型乳液及 W/0型乳液等乳液型者而已,可藉由選擇成份而同樣被 應用於透明型製劑。又,其他還可以做爲W/0型乳液或 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) (請先閲讀背面之注意事項再填寫本頁) Iη------訂------線 C — 經濟部中央標準局負工消費合作社印製 83.3. 10,000 經濟部中央標準局員工消費合作社印製 Α7 Β7 五、發明説明(6 ) 0/W型等多層乳化型製劑或微膠囊製劑化用之基礎技術 利用。 本發明之皮虜外用劑係只要可以適於外用者並不特別 限制,可做爲例如熱敷劑、育劑、糊劑、面霜劑、軟育劑 、噴霧劑、乳劑、化粧水劑、乳液、香精、敷面劑、凝膠 劑、粉劑粉底劑、防晒劑、沐浴精等做爲醫藥品、醫藥規 格外品、化粧品等公知形態廣泛地被應用。 調製本發明之外用劑時,有時可以配合其目的適當地 添加通常被使用之各種公知的有效成份,例如氯化己錠、 風箱樹素(cephalanthin)、維他命E、維他命E薛驗酸 、菸鹼酸、菸鹼醯胺、菸鹼酸苯甲酯、生薹汀、辣椒汀等 末梢血管擴張劑、樟腦、薄荷醇、薄荷油等清涼劑、日扁 柏醇、氯化苯甲烴銨、十一碳烯酸等抗菌劑、副腎皮質激 素、e-胺己酸、氯化溶菌酶、甘草素、尿囊素等消炎劑 、抗壞血酸、熊果苷等白色劑、胎盤抽出液、肝臟抽出液 、紫根精、乳酸菌培養抽出液等來自動物、植物、微生物 之各種抽出液等。 另外,上述之替藥品、醫藥規格外品、化粧品中還可 以在公知之有效成份外再添加油脂類等基劑成份,除此外 還可以視其需要併用公知之保濕劑、防腐劑、防氧化劑、 鉗合劑、p Η値調整劑、香料、著色劑等各種添加劑。 其次揭示實驗及處方例以說明本發明,惟此等例僅爲 揭示本發明之較佳實施形態者,對本發明並不做任何限定 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.3.10,000 (請先閲讀背面之注意事項再填寫本頁) 訂 線、 307682 五、發明説明(7 ) 〔實驗1〕 製劑安定性試驗 實驗方法: 以表1所揭示處方條件分別調製各種面霜製劑(p Η 値約4 5)。塡充此等製劑於4盎斯柱形瓶後,一邊照射 紫外線,一邊於5 0°C之嚴厲溫度條件下保存二個月。二 個月後測色差(ΛΕ)(使用日本電色工業Z1 001 DP色差計)。這時對外觀變化(有無紫外線吸收劑析出 ,乳化安定性)進行觀察,一併評估其使用感。 實驗結果 如表1所示,添加成份1〜8之本發明製劑係無紫外 線吸收劑之方法,乳化安定性亦極佳。又,製劑中之@ ^ 著色安定性亦佳,且被維持於極佳之使用感狀態。 *^ϋ· In «V . ^^1 «- -li ^^1 n n fa (請先閲讀背面之^fliv項再填寫本I) 訂_ 經濟部中央標準局員工消費合作社印製 83. 3. 10,000 本紙張尺度適用中國國家標準(CNS ) A4规格(210X297公釐) -10 五、 發明説明(8) A7 B7 經濟部中央榡隼局員工消費合作衽印製 表1-1供試試料及實驗結果 試 驗 結 果 成份名 實施 例 1 2 3 4 5 6 7 8 •期 m 5.00 5.00 2.00 _ _ •大豆憐脂質 一 2.00 — 1 "» _ 一 2.00 —- •憐脂酿膽鹼 — _ 5.00 — 0.50 — __ .神經鞘麵 一 — 一 0.50 一 _ .聚氧乙烯硬化娜油 — — — —- 1.50 — - __ .異硬脂酸聚氧乙烯硬化蓖麻油(60E. 0.) — _ — _ 0.50 .__^ - .聚氧乙嫌油 — — 一 一 — 1.50 _ _ .聚氧乙烯山梨糖醇蜜蠟 一 _ 一 — — 3.00 • Μ 庚 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 〇. 2 -羥基一4-甲氧基: 二苯甲酮 1.50 一 0.80 . 一 _ 1 4-第三丁基一4’ 一甲氧基一 一 1.00 0.50 一 — — 0.20 __ 二苯甲醯甲烷 2 .對胺基苯甲酸甘油酯 一 — — 0.20 — — 0.10 1.50 ^ . ί 暖乙二醇 — — 一 1.00 — — 4 .甲氧基肉桂醉酯 一 一 — 一 一 0.50 — 0.10 5 ·蜜蠘 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 6 .凡士林 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 7 ·荷荷巴油 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 8 _天然維他命E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 y .聚氧乙嫌十六院酸(2 5 E . 0.) 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 〇 ·聚氧乙嫌硬脂醚(2 0 E . 0.) 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 1 .羧乙烯聚雜 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 2 . d ]-祕垸酮竣_液 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 3.乙二胺四乙酸二納 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 4 ·檸麵 籠 織 触 龜 醜 紐 縫 5 ·檸檬齡內 籠 籠 触 徹畺 撇鲁 6 ·精製水 Ί 1—- 繼 繼 織 龜 醜 WS. 適量 外 紫外線吸棚之析出 — 無 析出 析出 析出 析出 析出 析出 観 乳倾態(有無分離) 〇 〇 〇 〇 „ 〇:良好△:—部份分離X :分離 U 〇 色差(ΛΕ値) 3.2 3.1 3.0 2.3 3.0 2.9 2.5 2.3 使 用 使用感fWS鱗 ◦:良好 粗糖 〇 〇 〇 〇 〇 〇 〇 〇 試 〇:幾乎沒有問題 粘糊感 〇 〇 〇 〇 〇 — 驗 △:稍有問題 U 〇 X :差 獅性 0 〇 〇 〇 〇 〇 〇 〇 (請先閲讀背面之"— v項再填寫本頁) 83. 3. !0,〇〇〇 -y 4Γ! 訂 -11 - 五、發明説明(q 成份名 A7 B7 表1-2供^^及實驗結果 以往之製 劑 賺節 比例 比較 例3 比較 例4 比較 例5 賊節 比例 例 比例 1 .逝基料 2 .大豆碟脂質 3 ·雜_膽鹸 4 .神經鞘麵 5 .聚氧乙烯硬化甚麻油 6 ·異晒旨酸聚氧乙烯硬化_油(60E.0.) 7 .聚氧乙嫌居麻油 8 ·聚氧乙烯山梨糖醇蜜敏 9 .麴酸 10. 2 —羥基一 4—甲氧基二苯甲酮 1 1 . 4 一第三丁基一 4,一甲氧基一 二苯甲醢甲烷 1 2 ·對胺基苯甲酸甘油酯 1 3 .柳酸乙二醇 14·甲氧基肉桂酸辛酯 - ο ο 8 5 0·0· (請先閲讀背面之注意事項再填寫本頁) - ! 二 50 10 50110 1 5 .蜜撤 1 6 .凡士林 1 7 .荷荷巴油 1 8 ·天然維他命E 1 9 .聚氧乙烯十六焼酸(2 5 E · 0.) 2 0 .聚氧乙烯ίΜΙ旨醚(2 0E. 〇·) 21 .羧乙烯聚合物 2 2 . <Π _妣略細竣觀液 2 3.乙二胺四乙酸二納 2 4. wm. 2 5. wmm 2 6.精製水 000400802fctt 580057000JJJ 4·27·°·1 <00-6°-微徽癒 000400802SSS 580057000 屯^^^^^^^黴歡適 0 0 0 4 0 5 8 0 0 5 4 2 7-0· ?70080002®® 量 I0·0·6·0·敝敗齋 000400802S6S 58005700033i 4.2 70-10-0-6°-微微適 ο ο ο 5 8 0 4 2 7 400802acfcs 057000Jii 0·1°·°·60·徽败趣 0004 008026Ϊ-6 580057000JJS 427·010·0·60·微黻適 000400802S&-&& 580057000ii_s 4·2 7·0·1°·ο·6·0·徽微龜 ο ο ο 5 8 0 4 2 >400802 歐££ >057000jj3 :0·10060·败黻適 訂 Ιί濟部中央標準局員工消費合作社印製 試驗結果 外觀 使用試驗 紫外線吸收劑之析出 乳倾態(有無分離) 〇:良好△ ··—部份分離X :分離 色差(ΔΕ値) 使用感評價郷 〇:良好 〇:鮮沒有問題 △:稍有問題 X :差 粗糖 粘糊感 獅性 無 刪 刪 删 議 触 000400802-ε-ε-κ ΠΡ 580057000«^s«3 UU 4· 27·0·.-·0·0·6·0·^^1·析 △ △ △307682 V. Description of the invention (1) The present invention is a group consisting of adding at least one selected from hydrocarbons, lipids, hardened or unhardened oils and fats to an agent containing kojic acid and / or its derivatives and ultraviolet absorbers, In order to improve the stability of the preparation of kojic acid and / or its derivatives, and make it a drug with performance. The representative dosage forms of Piru topical agents are 0 / W emulsions. Although the composition ratio or physical properties of water or oil are different from W / 0 emulsions, they all contain surfactants and can become water phase and oil phase. A uniform preparation that is emulsified and dispersed stably. As for the kojic acid and its derivatives that the applicant has been studying for many years in this case, they are well-known to have various excellent properties and high usefulness. The technical achievements have been disclosed in, for example, JP-A5 5-1 5 7 5 0 9 Gazette No. 5, 6-1 8 5 6 9 Gazette, Gazette No. 5 8-2 2 1 5 1 Gazette, Gazette No. 5 8-2 2 1 5 2 Gazette, Gazette No. 5 8 — 3 4 4 4 Bulletin No. 6, JP 6 0 — 7 9 6 No. 1, Bulletin No. 6 0 — 9 7 2 No. 2, JP No. 6 printed by the Employee Consumer Cooperative of the Central Standard Falcon Bureau of the Ministry of Economic Affairs No. 0 — 1 〇〇〇5, JP 6 0 — 1 3 7 2 5 No. 3, JP 6 1 — 1 〇4 4 No. 7, JP 6 1 — 6 0 8 0 1 Gazette No. 6-2 — 5 9 0 9 Gazette, Gazette No. 6 2 — 3 8 2 0 Gazette, Gazette No. 63—27322 Gazette, 83. 3.10,000 (Please read the notes on the back first Please fill in this page for details) This paper scale is applicable to China National Standard (CNS) A4 (210X297mm) 307682 V. Description of Invention (2) Japanese Patent Application No. 1 — 1 3 2 5 0 2 Gazette and Special Fairness 5 — 3 0 4 2 No. 2 Wait. However, to the best of our knowledge, this kojic acid and its derivatives (hereinafter collectively referred to as "kanoic acid") are drugs that are difficult to ensure their stability. For example, when you want to mix kojic acid in the above-mentioned o / w type emulsion or w / 〇 type emulsion for formulation, the prescription design must be a very high technology, so the development of wood will destroy the sense of use and can withstand the circulation of severe conditions. The preparation technology of the process has become a face-to-face topic in the preparation of kojic acid. When kojic acid is blended in various dosage forms, it will be exposed to ultraviolet rays that may cause kojic acid coloration and decomposition. For this reason, there are proposals for proper blending of ultraviolet absorbers, for example, Japanese Unexamined Patent Publication No. 6 2 _ 1 0 8 8 0 4, Japanese Unexamined Patent Publication No. 6.4-8 3 0 0 8 and Special Fair Publication No. 4-4 6 9 2 Bulletin 4 etc. However, most of these ultraviolet absorbers have solubility problems and often precipitate out in the formulation. Therefore, not only can the effects of the original ultraviolet absorbers not be fully exerted, but also the stability of kojic acid can be reduced. In order to solve this shortcoming, although appropriate dissolution aids are used, when a large amount of oily additives are printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs, they will produce a sticky feeling, which will have an adverse effect on the use of the agent. When using kojic acid externally, there are nonionic surfactants that are more suitable for use in terms of coloring stability, feeling of use, and safety of the skin. However, nonionic surfactants are used. Not only does it not have the same strong emulsifying properties as ionic surfactants, but it is also often affected by highly polar components or P Η value, and has the disadvantage of reducing emulsifying power, so for 83. 3.10,000 (please read the back side first (Notes and fill in this page again) This paper scale is applicable to China National Standards (CNS) Α4 specification (210Χ297mm) Printed by the Consumer Standardization Bureau of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs A 7 B7 V. Description of invention (3) often need to be adjusted p Η For kojic acid preparations with a value of 4 to 5, when blending a highly polar ultraviolet absorber, there is often a problem of lowering the emulsion stability over time. The present invention is to provide non-ultraviolet absorption by adding at least one kind selected from hydrocarbons, lipids, and hardened or unhardened oils and fats to external preparations containing kojic acid and / or its derivatives and ultraviolet absorbers Precipitation of the agent, and can improve the decomposition and discoloration of kojic acid, and it has excellent stability after a long period of time, and it is an external preparation with excellent skin characteristics for improving the performance of the drug. According to the present invention, it is possible to provide an external agent containing kojic acid and / or its derivatives and an ultraviolet absorber by adding at least one group selected from hydrocarbons, lipids, and hardened or unhardened oils and fats, thereby making it UV-free The precipitation of the absorbent, and can improve the decomposition of kojic acid color due to heat, and it still has excellent stability after a long time, and improves the sustained effect of the drug. The kojic acid used in the present invention as the first component (5-oxo-2-oxomethyl-? *-Pyrone) can be used 5-oxo-2-oxomethyl-r-pyrone The pure product is a fermented liquid containing lysic acid as the main component, a concentrated liquid of the fermented liquid obtained from the cultivation of well-known strains capable of producing ferric acid, and the fermented fermented fermented liquid from the fermented liquid. The kojic acid derivative may be, for example, one or a combination of two or more of Japanese Patent Publication No. 6 0-1 0 0 0 5, Japanese Patent Laid-Open No. 1-4 5 4 7 2, and Japanese Patent No. 3-7 4 2 2 9 , Japanese Unexamined Patent Publication No. 5 8 — 2 2 1 5 1 and Japanese Unexamined Patent Publication No. 5 8 — 2 2 1 5 2 etc., the esterified compounds of kojic acid and the -C H2〇H group at the two positions of kojic acid are bonded The size of the sugar paper is based on the Chinese National Standard (CNS) A4 specification (210X297mm) 83. 3.10,000 (please read the precautions on the back before filling this page) --------- book ------ Line "------ 307682 V. Description of the invention (4) Acids, derivatives and other well-known ones. 1 〜5 重量 % 范围。 For the formulation, the amount of kojic acid and / or its derivative is for all external preparations for 001 ~ 10 reset%, preferably 0.1 ~ 5 wt% range. The ultraviolet absorber used as the second component in the present invention is not particularly limited, but may be 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy, of the benzophenone series Benzophenone sulfonic acid, sodium oxymethoxy benzophenone sulfonate, dihydroxydimethoxy benzophenone, etc., salicylic acid ethylene glycol, salicylic acid high ester, salicylic acid benzene Esters, urinary acid and ethyl urinary acid, p-methoxycinnamic acid 2-ethylhexyl ester of carnitic acid series, methoxy * cinnamic acid octyl ester, etc., p-aminobenzene of p-aminobenzoic acid series Glycerol formate, 2-ethylhexyl p-dimethylaminobenzoate, 4-dibutylmethane 4-tertiary butyl 4 >-methoxydibenzoylmethane, etc. or benzotriazole Part 2-(2-hydroxy-5-tolyl) benzotriazole is more suitable, and these can be used alone or in combination of two or more. In addition, other well-known animals having ultraviolet absorption energy can be combined with plant extracts as appropriate. 1 001〜10 重量 % , 优选 为 0.1 ~ 5 wt%. As the hydrocarbon used as the third component of the present invention, for example, α-olefin oligomers, flowing isoparaffins, plastic base material Plastibase, manufactured by Squeeve Co., Ltd.), polyisobutylene, polybutene and other chains can be suitably used. Alkane hydrocarbons or olefin hydrocarbons, especially those with a low polarity of more than 10 carbons, 83.3.10,000 (please read the precautions on the back before filling out this page) This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) A7 B7 307682 V. Description of invention (5) Lipids are most suitable for phospholipids, specifically, phospholipid choline, phospholipid muscle extracted from natural products such as yolk, soybean, corn, etc. Alcohol, phosphatidylethanolamine, phosphatidylserine and other glycerophospholipids, sphingomyelin, sphingosine, aminoethylphosphoric acid, and other sphingomyelins, sphingolipids, distearoylphosphatidylcholine, choline, dipalmitoside Synthetic phospholipids based on phospholipids such as cholesteryl phosphatidylcholine. The hardened or unhardened oils and fats are, for example, polyoxyethylene hardened castor oil, triisostearic acid polyoxyethylene hardened castor oil, isostearic polyoxyethylene hardened castor oil, lauric acid polyoxyethylene hardened castor oil, polyoxyethylene Hardened castor oil, polyoxyethylene sorbitol beeswax, etc. are suitable for fully hardened castor oil with a degree of polymerization of about 40 to 1,000. These can be used alone or in combination of two or more. The compounding amount of the third component of these inventions varies depending on the kind, but it is usually 〇: ο 〇 1 ~ 2 0 reset% for the total amount of external agent, preferably 0.1 ~ 10% by weight. When the above-mentioned external preparations with the first to third component groups as essential components are manufactured according to a well-known manufacturing method, a stable and stable emulsified preparation can be obtained without precipitation of ultraviolet absorbers. In addition, it can significantly improve the shortcomings of discoloration and decomposition of kojic acid in this preparation. In addition, it can also improve its transdermal absorption capacity. Therefore, it can provide a skin external preparation that can continuously exert the efficacy of kojic acid. The above-mentioned preparation of the present invention is of course not limited to emulsion types such as 0 / W emulsions and W / 0 emulsions, and can also be applied to transparent formulations by selecting ingredients. In addition, the other can also be used as W / 0 emulsion or the paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) (please read the precautions on the back before filling this page) Iη ------ Order --- Line C — Printed by the Consumer Labor Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 83.3. 10,000 Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics Α7 Β7 V. Description of the invention (6) 0 / W type multi-layer emulsification Utilize the basic technology for the preparation of type preparations or microcapsules. The skin external preparation of the present invention is not particularly limited as long as it can be suitable for external use, and can be used as, for example, a hot compress, an incubator, a paste, a cream, an incubator, a spray, an emulsion, a lotion, an emulsion, Flavors, facial masks, gels, powder foundations, sunscreens, bath essences, etc. are widely used as well-known forms such as pharmaceuticals, non-medicinal products, and cosmetics. When the external preparation of the present invention is prepared, various commonly known effective ingredients such as hexyl chloride, cephalanthin, vitamin E, vitamin E, hexanoic acid, etc. may be appropriately added according to the purpose. Peripheral vasodilators such as nicotinic acid, nicotinic amide, benzyl nicotinate, raw corydine, capsaicin, camphor, menthol, peppermint, etc., hinokitiol, benzalkonium chloride, Antimicrobial agents such as undecylenic acid, pararenal corticosteroids, e-aminocaproic acid, lysozyme chloride, glycyrrhizin, allantoin and other anti-inflammatory agents, white agents such as ascorbic acid and arbutin, placenta extract, liver extract , Radix extract, lactic acid bacteria culture extracts, etc. from animals, plants, microorganisms and other extracts. In addition, the above-mentioned substitute medicines, non-pharmaceutical products, and cosmetics can be added with base ingredients such as fats and oils in addition to known effective ingredients. In addition, known moisturizers, preservatives, antioxidants, Various additives such as sequestering agents, pH modifiers, fragrances, colorants, etc. Secondly, experiments and prescription examples are disclosed to illustrate the present invention, but these examples are only to disclose the preferred embodiments of the present invention, and the invention is not limited to this. The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm ) 83.3.10,000 (please read the precautions on the back before filling in this page). Line, 307682 V. Description of the invention (7) [Experiment 1] Experimental method of stability test of the preparation: According to the prescription conditions disclosed in Table 1, various creams are prepared separately Preparation (p Η value about 45). After filling these formulations in 4 ounce cylindrical bottles, they were stored under severe temperature conditions of 50 ° C for two months while irradiating ultraviolet rays. Two months later, the color difference (ΛΕ) was measured (using Japan Denshoku Industries Z1 001 DP color difference meter). At this time, the appearance change (presence or absence of ultraviolet absorber, emulsification stability) was observed, and the feeling of use was evaluated together. Experimental results As shown in Table 1, the preparation of the present invention in which ingredients 1 to 8 are added is a method without UV absorber, and the emulsification stability is also excellent. In addition, the coloring stability of @ ^ in the preparation is also good, and it is maintained in an excellent state of use. * ^ ϋ · In «V. ^^ 1«--li ^^ 1 nn fa (please read the ^ fliv item on the back and then fill in this I) Order _ Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy 83. 3. 10,000 paper scales are applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) -10 V. Description of invention (8) A7 B7 Employee's Consumer Cooperation Cooperative Printed Table 1-1 for trial and experiment Results Test Results Ingredient Name Example 1 2 3 4 5 6 7 8 • Period m 5.00 5.00 2.00 _ _ • Soybean phospholipid one 2.00 — 1 " »_ one 2.00 —- • Phosphatidylcholine — _ 5.00 — 0.50 — __. Nerve sheath surface one — one 0.50 one _. Polyoxyethylene hardened na oil — — — — 1.50 —-__. Isostearic polyoxyethylene hardened castor oil (60E. 0.) — _ — _ 0.50 .__ ^-.Polyoxyethylene suspected oil-one one-1.50 _ _. Polyoxyethylene sorbitol beeswax one _ one-3.00 • Μ 庚 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 〇. 2-hydroxy one 4-Methoxy: Benzophenone 1.50-0.80. One _ 1 4-T-butyl-4'-methoxy One one 1.00 0.50 one — 0.20 __ Dibenzomethane 2. Glyceryl p-aminobenzoate one — 0.20 — — 0.10 1.50 ^. Ί Warm ethylene glycol — One 1.00 — — 4. Methoxy cinnamon Drunken Ester One One One One One One One One One One 0.50 One One One One One One One One One One One One Vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 y. Polyoxyethyl hexadecanoic acid (2 5 E. 0.) 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 〇. Polyoxyethyl acetyl stearate (2 0 E. 0.) 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 1. Carboxyvinyl heteropoly 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 2 .d) -Secretone complete liquid 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 3. Ethylenediamine tetra Dina Acetate 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 4 · Lime-faced cage weaving the tortoise ugly seam 5 · Lemon-aged inner cage weaving the tortoise 6 · Refined water Ί 1—- Following the weaving tortoise ugly WS. External ultraviolet Shed precipitation — no precipitation precipitation precipitation precipitation precipitation precipitation milky state (with or without separation) 〇〇〇〇 „〇: good △:-partial separation X: separation U 〇 color difference (ΛΕ 値) 3.2 3.1 3.0 2.3 3.0 2.9 2.5 2.3 Use feeling fWS scale ◦: Good raw sugar 〇〇〇〇〇〇〇〇 test: almost no problem sticky feeling 〇〇〇〇-test △: slightly problem U 〇X: poor lion sex 0 〇〇 〇〇〇〇 (please read the "quote-v item on the back and then fill in this page) 83. 3.! 0, 〇〇〇-y 4Γ! Order-11-V. Description of invention (q component name A7 B7 Table 1 -2 for ^^ and the experimental results of the previous preparations of the proportion of the festival comparison example 3 comparison example 4 comparison example 5 thief section ratio example ratio 1. dead base 2. soybean dish lipid 3 · miscellaneous_ gallbladder 4. nerve sheath surface 5 .Polyoxyethylene hardened very sesame oil 6 · Isolated acid polyoxyethylene hardened _ oil (60E.0.) 7. Polyoxyethylene suspected sesame oil 8 · Polyoxyethylene sorbitol honey sensitive 9. Ascorbic acid 10. 2 —Hydroxy-4-methoxybenzophenone 1 1.4 A third butyl 4, a methoxy Benzene dibenzomethane 1 2 · Glyceryl p-aminobenzoate 1 3. Ethylene glycol salicylate 14 · Octyl methoxycinnamate-ο ο 8 5 0 · 0 · (Please read the notes on the back first (Fill in this page again)-! Two 50 10 50110 1 5. Honey withdrawal 1 6. Vaseline 1 7. Jojoba oil 1 8 · Natural vitamin E 1 9. Polyoxyethylene hexadecanoic acid (2 5 E · 0. ) 2 0. Polyoxyethylene ΙΜΙ purpose ether (2 0E. 〇.) 21. Carboxyethylene polymer 2 2. ≪ Π _ 妣 slightly finely finished liquid 2 3. Ethylenediaminetetraacetic acid dioxin 2 4. wm . 2 5. wmm 2 6. Refined water 000400802fctt 580057000JJJ 4.27 · ° · 1 < 00-6 ° -Weihuiyu 000400802SSS 580057000 Tun ^^^^^^^ Mild suitable 0 0 0 4 0 5 8 0 0 5 4 2 7-0 ·? 70080002®® quantity I0 · 0 · 6 · 0 · Xi Baizhai 000400802S6S 58005700033i 4.2 70-10-0-6 ° -slightly suitable ο ο 5 8 0 4 2 7 400802acfcs 057000Jii 0 · 1 ° · ° · 60 · Hui Huiqiu 0004 008026Ϊ-6 580057000JJS 427 · 010 · 0 · 60 · Weifushi 000400802S &-& & 580057000ii_s 4 · 2 7 · 0 · 1 ° · ο · 6 · 0 · Hui Weigui ο ο ο 5 8 0 4 2 > 400802 Euro £ > 057000jj3: 0 · 10060 Printed test results of the Employees ’Cooperatives of the Bureau of Appearance Appearance of using the test UV absorber to determine the milk shedding state (with or without separation) ○: Good △ • Partial separation X: Separation color difference (ΔΕ 値) Evaluation of use feeling 〇: Good 〇 : There are few problems △: Slight problems X: Poor coarse sugar sticky feeling lion-like without deletion, deletion, deletion, contact 000400802-ε-ε-κ ΠΡ 580057000 «^ s« 3 UU 4.27 · 0 · .- · 0 · 0 · 6 · 0 · ^^ 1 · Analysis △ △ △

XX

XX

XX

XX

X △ 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐)X △ This paper scale is applicable to China National Standard (CNS) Α4 specification (210Χ297mm)

XX

X —t> △ △X —t > △ △

XX

XX

XX

XX

XX

XX

XX

X △X △

X 厶 △ △X 厶 △ △

X XX X

X XX X

XX

X △ 83. 3. !0,〇〇〇 307682 ^ 五、發明説明(ίο) 〔實驗2〕 天竺鼠之抑制紫外線色素沉澱效果。 使用黃褐色天竺鼠,調査色素沉澱之改善效果。示結 果於表2。 由表2可知本發明製劑具有優異之色素沉澱抑制效果 ’且確認其爲可長時間持績藥效之製劑 复_驗方法 使用黃褐色天竺鼠之背部皮虜,以推剪器(剃)除該 天竺鼠之背部毛,再以電動刮鬍刀刮除毛。以設有四個正 方形(2. 0X2. 0cm)開孔之鋁箔罩住此天竺鼠背 部,每次照射1次UV-B (SE燈3支,1 4 OmJ/ cm2) 9 0秒,每三天照射4次。開始照射後,在天竺鼠 之被檢部份連續每天塗佈3次實驗1所調製之製劑,連績 1 0天。自開始塗佈後第1 0天第2 0天測定色素沉澱。 皮虜色變黑之程度得以肉眼依以下基準測定。 判定某準 經濟部中央標準局員工消費合作社印製 3:完全未見色素沉激 2 :稍有色素沉澱 1 :可確認有中程度之色素沉澱 〇 :與對照部位(未予處置者)相同 —1 :較對照部位(未予處理者)有更深之色素沉澱。 83. 3.10,000 (請先聞讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家揉準(CNS > A4規格(210X297公釐)X △ 83. 3.! 0, 〇〇〇 307682 ^ V. Description of the invention (ίο) [Experiment 2] The effect of guinea pigs to suppress ultraviolet pigmentation. A yellow-brown guinea pig was used to investigate the improvement of pigmentation.示 结果 于 表 2。 The results are shown in Table 2. It can be seen from Table 2 that the preparation of the present invention has an excellent pigmentation inhibitory effect 'and it is confirmed to be a preparation that can maintain the medicinal effect for a long time. Re-test method uses the back skin of a yellow-brown guinea pig and removes it with a clipper (shave) The hair on the back of the guinea pig is then shaved with an electric razor. Cover the back of the guinea pig with aluminum foil with four square (2.0X2.0cm) openings, and irradiate UV-B (3 SE lamps, 1 4 OmJ / cm2) for 90 seconds every three days. 4 exposures. After the start of irradiation, the preparation prepared in Experiment 1 was applied to the tested part of the guinea pig three times a day for 10 consecutive days. Pigmentation was measured on day 10 and day 20 after the start of application. The degree of darkening of the skin color can be measured with the naked eye according to the following criteria. Judgment: Printed by an employee consumer cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 3: No pigmentation shock at all 2: Slight pigmentation 1: A moderate degree of pigmentation can be confirmed: Same as the control part (untreated) — 1: There is deeper pigmentation than the control part (untreated). 83. 3.10,000 (please read the precautions on the back and then fill out this page) This paper size is suitable for China National Standard (CNS > A4 specification (210X297mm)

A B 經濟部中央標準局貝工消費合作社印製 五、發明説明(11 ) 表2 -1實驗結果 實施例 1 2 3 4 5 6 7 8 1 .塑基料 5.00 5.00 2.00 2 .大豆磷脂質 — 2.00 — — — — 2.00 — 3.鱗脂酉 _鹸 — — 5.00 — 0.50 — — — 4 .神經鞘麵 5 .聚氧乙烯硬化娜油 _______ — ______ 0.50 1.50 — — — 6 .異硬I旨酸聚氧乙烯硬化甚麻油(60E.O.) — — — — — 0.50 — — 7 .聚氧乙嫌_油 — — — — — — 1.50 — 8 ·聚氧乙烯山梨糖醇蜜蠘 — — — — — — 3.00 9 .麴酸 1.⑻ 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.2- -羥基一4—甲氧基二苯甲_ 1.50 — 0.80 11.4- -第三丁基一4, —甲氧基— 一 1.00 0.50 — — — 0.20 — 二苯甲醯甲烷 1 2 ·對胺基苯甲酸甘油酯 — — —— 0.20 — — 0.10 1.50 13.· 矣乙二醇 — — — — 1.00 — — — 1 4 .甲氧基肉桂酸辛酯 0.50 — 0.10 1 5 .蜜鲺 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 1 β .凡士林 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 1 7 .荷荷巴油 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 1 8 ·天然維他命Ε 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 1 9 .聚氧乙嫌十六院醚(2 5 Ε . 0.) 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 2 0 .聚氧乙嫌硬脂醚(2 0 Ε. 0.) 0.70 0.70 0.70 0,70 0.70 0.70 0.70 0.70 2 1 .羧乙烯聚合物 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 2 2 . d ] 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 2 3 _乙二胺四乙酸二納 2 4 . 酸 2 5 . 0.02 麗 麵 0.02 繼 麵 0.02 讎 観 0.02 繼 繼 0.02 麵 繼 0.02 麵 麵 0.02 籠 讎 0.02 ms. WM. 2 6.精製水 繼 mm. 麵 継 繼 腿 縫 適量 效果測定 第1 0天 0 0 0 0 0 0 0 0 第2 0天 3 3 3 3 3 3 3 3 ---------------^______丁______泉- 、v* 髮/ (請先閱讀背面之注意事項再填寫本頁) 本紙張尺度適用中國國家樣準(CNS ) A4規格(210X297公釐) 83. 3. 10,000 307682 g 五、發明説明(l2 ) 表2-2供試試料及實驗結果 以往之製劑 比較 例1 比較 例2 比較 例3 比較 例4 比較 例5 比較 例6 比較 例7 比較 例8 比較 例9 1 .塑基料 — _ — — — — — — — 2 .大豆磷脂質 — — 3 ·磷脂醯膽鹸 — — — — — — — — — 4 .神經鞘_ — 一 — — 5 .聚氧乙烯硬化讎油 — 6 .異硬脂酸聚氧乙烯硬化蔑麻油(60E.O.) 7 .聚氧乙烯蔑麻油 8 .聚氧乙烯山梨糖醇蜜蠘 — — 9 .麴酸 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.2- -經基一4 —甲氧基二苯甲酮 — 1.50 — 0.80 — — — — — 11.4- -第三丁基一 4 ’ —甲氧基一 — — 1.00 0.50 — — — 0.20 —— 二苯甲醯甲烷 1 2 .對胺基苯甲酣油酯 — — — — 0.20 — — 0.10 1.50 1 3 .柳酸乙二醇 1.00 — — — 1 4 .甲氧基肉桂酸辛豳 0.50 _ 0.10 1 5 .蜜嫩 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 1 β .凡士林 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 1 7 .荷荷巴油 7.00 7.00 7.00 7.00 7.00 7_⑻ 7.00 7.00 7.00 1 8 .天然維他命Ε 0.04 0.04 0.04 0.04 0.04 0.04 0,04 0.04 0.04 1 9 .聚氧乙烯十六院醚(2 5 Ε. 0.) 1.50 1.50 1.50 1.50 1,50 1.50 1.50 1.50 1.50 2 0 ·聚氧乙嫌硬脂醚(2 0 Ε. 0.) 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 2 1 .羧乙烯聚合物 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0;08 2 2 . d 1 一紕略院酮竣麵液 6.00 6.00 6.00 6.00 '6.00 6.00 6.00 6.00 6.00 2 3.乙二胺四乙酸二鈉 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 2 4 .嬾 酿 繼 讎 醒 讎 WM. 観 ms. 繼 2 5. mmm 籠 繼 讎 繼 観 諷 微量 η 2 6 .精製水 適量 適童 適量 適量 適量 適量 適量 適量 適量 效果測定 色素沉酿 第1 0天 0 0 0 0 0 0 0 0 0 第2 0天 1 1 1 1 I1 1 1 1 1 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 (請先閲讀背面之注意事項再填寫本頁) A7 B7 五、發明説明(13 ) 〔處方例〕 量 重 ο ο IX 爲 體 全 方 處 使 可 〇 指 例係 方 J 處量 之適 明 Γ 發, 本中 舉例 下方。 以處量 之 % ---Ί i ^----^------訂------線( (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度逋用中國國家標準(CNS〉A4規格(210X297公釐〉 83.3. 10,000 BQ7682__五、發明説明(l4 ) 〔處方例1〕 面霜(1 ) % 量 重 麻醚 Μ烷 化六 I 鹸硬十 基膽烯烯 羥醯乙乙 酸 I 脂氧氧 麴 2 磷聚聚 4 酮 甲 苯 二 基 氧 甲 E ο 4 ο E 5 2 酸油油 脂梨仁 硬酪杏 液 鈉 酸 羧酯鈉 酮酸酸 烷甲乙 咯苯四 吡基胺水 I 羥二製 1 對乙精 d · . _ ooooooooool 05000000020 (請先閣讀背面之注意事項再填寫本頁) 適 量 經濟部中央標準局貞工消費合作社印製 本紙張尺度逍用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 17 - A7 B7 五、發明説明(15 ) 〔處方例2〕 面霜(2 ) 重量% 酸 麴 ο ο 4 甲醯乙料乙巴 苯脂氧基氧荷 二磷聚塑聚荷 基烷胺麻 丁 甲醇箆 三醯乙烯 第 旨 月 毛 羊 烯油 4 基 氧 甲 ο ο ο ο 2 ο ο ο ο ο ο ____________ (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 液 溶 水 鈉 烷烷烷 鈉 二 氧氧氧 E 酸 酸 矽矽矽命質 乙 戊四聚他明膠四 環環基維透菜胺水 基基甲然%角二製 甲甲二天 1 鹿乙精 十八 · ο ο ο ο ο ο 4 ο ο ο ο ο IX ο 適 量 -訂 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 18 - A7 B7 五、發明説明(16 ) 〔處方例3〕 乳液(1 ) 麴酸 對甲氧基肉桂酸2 —乙基己酯 角鯊烷 神經醯胺 聚氧乙烯十六烷醚(2 5E. 聚氧乙烯油醚 硬脂酸 牛油樹脂肪 酪梨油 .對羥基苯甲酸酯 .橡梓籽精 .漢生膠 .乙二胺四乙酸二鈉 .精製水 重置% 1.00 0 〇 0 0 0 0 0 0 0 0 0 0 適 量 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙悵尺度適用中國國家揉準(CNS ) A4規格(?10X297公釐) 83. 3. 10,000 -19 - 307682_五、發明説明(l7 ) 〔處方例4〕 乳液(2 ) % 量 重 蠟 蜜 酯醇 辛糖 酸梨 醇桂山 二肉烯 乙基乙 酸酸氧氧 麴柳甲聚 ο 5 ο ο ο ο 5 I 酸酸 蠟酸 命甲鈉 乙 石肪 他苯酸 四 動脂 酸 維基質膠胺水 流油酸蔻油然羥明生二製 質子脂豆梨天對透漢乙精 輕椰硬肉酪...... 胺 醯 醇 乙 as 鈉 適 ο ο ο ο ο 5 ο 5 ο ο 4 ο ο 2 ο ο 4 1 1 ο 量 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家橾準(CNS〉A4規格(210X297公釐) 83. 3.10,000 20 A7 B7 五、發明説明(IS ) 〔.處方例5〕 化粧水 (重量% ) 縮丁 甲乙聚乙精精基血檬%二製 酸三苯 I 桂氧參藥羥壞檸 5 乙精 麴第二 2 月聚人當對抗 .· . _ 〇 酯 · 己 E 酸油 Q 桂麻 6 肉 Μ 丨 I 基化醚 . 氧硬烷 油 4 烷甲烯六 甘 I 甲對乙十 水基醯基氧烯 基 氧 甲 液 解鈉 水二 酯 白酸 酸 蛋乙 甲 鈉性四 苯酸酸彈胺水 適 ο ο ο ο 5 0 0 ο ο ο ο ο ο 5 ο ο ο IX IX 0〇 ο ο IX ο 量Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (11) Table 2 -1 Experimental results Example 1 2 3 4 5 6 7 8 1. Plastic base 5.00 5.00 2.00 2. Soybean phospholipid — 2.00 — — — — 2.00 — 3. Scale fat unitary _ 鹸 — — 5.00 — 0.50 — — — 4. Nerve sheath surface 5. Polyoxyethylene hardened Na oil _______ — ______ 0.50 1.50 — — — 6. Isostearic acid Polyoxyethylene hardened very hemp oil (60E.O.) — — — — — 0.50 — — 7. Polyoxyethylene suspected oil — — — — — — 1.50 — 8 • Polyoxyethylene sorbitol honey beetle — — — — — — 3.00 9.. Ascorbic acid 1. ⑻ 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.2- -Hydroxy-4—methoxydibenzoyl_ 1.50 — 0.80 11.4- -Third butyl-4, —methoxy-1- 1.00 0.50 — — — 0.20 — Dibenzoylmethane 1 2 · Glyceryl p-aminobenzoate — — —— 0.20 — — 0.10 1.50 13. · Glycol — — — 1.00 — — — 1 4. A Octyl oxycinnamate 0.50-0.10 1 5. Honey catfish 4.50 4.50 4.50 4.5 0 4.50 4.50 4.50 4.50 1 β. Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 1 7. Jojoba oil 7.00 7.00 7.00 7.00 7.00 7.00 7.00 7.00 1 8 Natural Vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0.04 0.04 1 9 .Polymer Oxyethine hexadecyl ether (2 5 Ε .0.) 1.50 1.50 1.50 1.50 1.50 1.50 1.50 1.50 2 0 .Polyoxyethylene ethoxystearyl ether (2 0 Ε. 0.) 0.70 0.70 0.70 0,70 0.70 0.70 0.70 0.70 2 1. Carboxyethylene polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 2 2. D] 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 2 3 _ ethylenediaminetetraacetic acid dina 2 2. Acid 2 5. 0.02 Limian 0.02 Follow surface 0.02 雠 観 0.02 follow 0.02 face follow 0.02 face 0.02 cage face 0.02 ms. WM. 2 6. Refined water follow mm. Face to follow the appropriate amount of leg seam measurement Day 10 0 0 0 0 0 0 0 0 0 Day 2 0 3 3 3 3 3 3 3 3 --------------- ^ ______ 丁 ______ 泉-, v * hair / (Please read the precautions on the back first (Fill in this page) This paper size is applicable to China National Standards (CNS) A4 specification (210X297mm) 83. 3. 10,000 307682 g V. Description of invention (l2) Table 2-2 for testing Materials and Experimental Results Conventional Preparations Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 Comparative Example 5 Comparative Example 6 Comparative Example 7 Comparative Example 8 Comparative Example 9 1. Plastic Base — _ — — — — — — — 2. Soybean Phospholipid-3 · Phospholipid gallbladder---------4. Nerve sheath _---5. Polyoxyethylene hardened chopped oil — 6. Isostearic acid polyoxyethylene hardened sesame oil ( 60E.O.) 7. Polyoxyethylene sesame oil 8. Polyoxyethylene sorbitol honey beetle-9-Ascorbic acid 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 10.2- -Methyl-4-methoxydibenzene Methyl ketone — 1.50 — 0.80 — — — — — 11.4- -Third butyl 4 ′ —Methoxy mono — 1.00 0.50 — — — 0.20 —— Dibenzoylmethane 1 2. P-aminobenzophenone Oil esters — — 0.20 — — 0.10 1.50 1 3. Ethylene glycol salicylate 1.00 — — — 1 4. Methoxycinnamic octanoate 0.50 _ 0.10 1 5. Honey tender 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 4.50 1 β. Vaseline 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 2.80 1 7. Jojoba oil 7.00 7.00 7.00 7.00 7.00 7_⑻ 7.00 7.00 7.00 1 8. Natural Vitamin E 0.04 0.04 0.04 0.04 0.04 0.04 0,04 0.04 0.04 1 9 .Polyoxygen Ethylene hexadecyl ether (2 5 Ε. 0.) 1.50 1.50 1.50 1.50 1,50 1.50 1.50 1.50 1.50 2 0 Polyoxyethylene stearate (2 0 Ε. 0.) 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 0.70 2 1. Carboxyethylene polymer 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0.08 0; 08 2 2. D 1 Yiliuyuan Ketone Complete Solution 6.00 6.00 6.00 6.00 '6.00 6.00 6.00 6.00 6.00 2 3. Ethylenediaminetetraacetic acid Disodium 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 0.02 2 4. Lazy brewing followed by awakening WM. 観 ms. Following 2 5. mmm cage following 雠 followed by sarcasm trace amount η 2 6. Refined water appropriate amount suitable child appropriate amount appropriate amount appropriate amount Determination of the effect of the right amount of the right amount of pigmentation brewing Day 1 0 0 0 0 0 0 0 0 0 0 0 Day 2 0 1 1 1 1 1 I1 1 1 1 1 The paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm ) 83. 3.10,000 (Please read the notes on the back first Then fill page) A7 B7 V. invention is described in (13)] [Formulation weighing ο ο IX to the body so that all parties may refer to the amount of square-based side adapted from Example J Γ out hair, the present exemplified below. Take the% of punishment --- Ί i ^ ---- ^ ------ order ------ line ((please read the precautions on the back before filling out this page) Staff of Central Bureau of Standards, Ministry of Economic Affairs The paper printed by the consumer cooperative uses the Chinese national standard (CNS> A4 size (210X297mm> 83.3. 10,000 BQ7682__V. Description of the invention (l4)) [Prescription Example 1] Face cream (1)% Amount of heavy hemp ether Hexa I Idecadecylcholene hydroxyacetate I Lipoxygen 2 Phosphate poly 4 ketotolyloxymethyl E ο 4 ο E 5 2 Sour oil, fat, pear, hard case, apricot liquid, sodium carboxylate Sodium ketoacid, alkyl, methyl, ethyl, pyrrol, tetrapyrylamine, water, I, hydroxy, 2, 1, ethyl, d.. _ Ooooooooool 05000000020 (please read the precautions on the back before filling this page) Appropriate amount of consumption by the Ministry of Economic Affairs Central Standards Bureau The paper printed by the cooperative is used in the Chinese National Standard (CNS) A4 specification (210X297 mm) 83. 3.10,000 17-A7 B7 5. Description of the invention (15) [Prescription Example 2] Face cream (2) Weight% Koji ο ο 4 Carboxylic acid ethyl ethyl phenoxyl oxygen oxy-charged phosphorous polyplastic polyhexylamine amine butadiene methanol methanol triethylene vinyl Moonhair sheep oil 4 base oxymethine ο ο ο ο 2 ο ο ο ο ο ____________ (please read the precautions on the back before filling in this page) Central Government Bureau of Economic Affairs Employee Consumer Cooperative Printed liquid soluble sodium alkane Sodium alkoxide, dioxygen, oxygen, E, acid, silicon, silicon, silicon, life quality, Ethylene tetramer, Gelatin, Tetracyclic Cyclic, Vitramine, Aqueous, Aqueous,%, Koji, A, A, A, 2, 1, Deer, Essence, 18, ο ο ο ο ο ο 4 ο ο ο ο ο IX ο Appropriate amount-the size of the paper edition is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) 83. 3.10,000 18-A7 B7 5. Description of the invention (16) [Prescription Example 3] Emulsion (1) P-methoxycinnamic acid 2-ethylhexyl squalane squalane neuroamide polyoxyethylene cetyl ether (25E. Polyoxyethylene oleyl stearate shea butter fat casein Pear oil. Parabens. Oak seed extract. Xanthan gum. Disodium edetate. Purified water reset% 1.00 0 〇0 0 0 0 0 0 0 0 0 0 0 Appropriate amount (please read the back first Please pay attention to this page and then fill out this page.) The printed standard paper of the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs is applicable to the Chinese country. Standard (CNS) A4 specification (? 10X297mm) 83. 3. 10,000 -19-307682_ V. Description of the invention (l7) [Prescription Example 4] Emulsion (2)% amount of heavy wax honey ester alcohol octyl sorbitol Guishan Dimethoxyethyl Acetate Oxymethoate Meglucan ο 5 ο ο ο ο 5 I Acid Acid Waxic Acid Sodium Methionate Ethyl Fatty Acid Tetamic Acid Tetrakinic Acid Vitamin Matrigel Water Flow Oleic Acid Cardamom Ranran Hydroxylamine Proton Fat Bean Pear Sky Pair Trans Han Yi Jing Light Coconut Hard Meat Case ... Acetoacetate as sodium suitable ο ο ο ο ο 5 ο 5 ο ο 4 ο ο 2 ο ο 4 1 1 ο amount ( Please read the precautions on the back before filling out this page) The paper standard printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs is applicable to the Chinese National Standard (CNS> A4 specifications (210X297 mm) 83. 3.10,000 20 A7 B7 V. Description of the invention (IS) [. Prescription Example 5] Make-up water (% by weight) Butyric acid methyl ethyl ethyl spermidine base blood lemon% triacid triphenyl I Guixi ginseng hydroxycarbohydrate 5 ethyl alcohol second month poly When people fight ... _ 〇 ester · hex E acid oil Q Guima 6 meat M 丨 I based ether. Oxydane oil 4 alkyl methene hexaglycol I A to ethyl decahydrate Acetyloxyalkenyloxymethyl hydrolysate sodium water diester leucoic acid egg ethyl methyl sodium tetrabenzoate ammonium hydroxide water suitable ο ο ο ο 5 0 0 ο ο ο ο ο ο 5 ο ο ο IX IX 0〇 ο ο IX ο amount

Bt^i· n^i leu I i''J· i m^i n (請先閣讀背面之注意事項再填寫本頁) 訂 線-^ 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) Α4規格(210 X 297公釐) 83. 3. 10,000 A7 B7 五、發明説明(l9 ) 〔處方例6〕 敷面眘 麴酸乙酯 4 一第三丁基 4 甲氧基 二苯甲醯甲烷 三異硬脂酸聚氧乙烯硬化箆麻油 (1 Ο Ο E .〇.) 磷脂醯肌醇 硬脂酸二乙醇醯胺 硬脂酸 肉豆蔻酸 椰子油 天然維他命E .對羥基苯甲酸酯 d 1 吡咯烷酮羧酸鈉液 乙二胺四乙酸二鈉 精製水 (重量% ) 2.00 0.50 2.00 5.00 5.00 5.00 0.50 5.00 0.04 0.20 5.00 0.01 適 量 (請先閱讀背面之注意事項再填寫本頁) ivBt ^ i · n ^ i leu I i''J ・ im ^ in (please read the notes on the back first and then fill in this page) Thread- ^ Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The paper size is applicable to China National Standard (CNS) Α4 specification (210 X 297 mm) 83. 3. 10,000 A7 B7 5. Description of the invention (l9) [Prescription Example 6] Ethyl ethyl methacrylate 4-third butyl 4 methoxy Dibenzoylmethane triisostearic acid polyoxyethylene hardened sesame oil (1 Ο Ο E.〇.) Phosphatidyl inositol stearic acid diethanol amide stearic acid myristic acid coconut oil natural vitamin E. para-hydroxyl Benzoate d 1 Pyrrolidone Carboxylic Acid Sodium Solution Ethylenediaminetetraacetic acid disodium purified water (% by weight) 2.00 0.50 2.00 5.00 5.00 5.00 0.50 5.00 0.04 0.20 5.00 0.01 Appropriate amount (please read the precautions on the back before filling this page) iv

a^m vm - ^ —Β^ϋ m^i ^^^^1 —Bn m>R k— · 、\$ 髮 J 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83.3. 10,000 A7 B7 五、發明説明(2〇 ) 〔處方例7〕 軟膏劑 (重量% ) 酸 磺 酮 甲 苯 二 鈉 胺 基酸醯 氧磺醇 鈉 甲酮乙 酯二 一甲 I 酸酸 4 苯酸 甲乙 I 二肪 苯膠四 基酯基 脂 油基菜胺水 羥苯氧料油林酸 欖羥角二製 酸 I 酸甲基子士脂酸橄對鹿乙精 麴 2 柳羥塑椰凡硬油..... . . . . . . . . 0 12 3 4 12345678911111a ^ m vm-^ —Β ^ ϋ m ^ i ^^^^ 1 —Bn m > R k— ·, \ $ Fa J The Central Standards Bureau of the Ministry of Economic Affairs of the People ’s Consumer Cooperative printed this paper. The standard of the paper is China National Standards (CNS ) A4 specification (210X297mm) 83.3. 10,000 A7 B7 V. Description of the invention (2〇) [Prescription Example 7] Ointment (wt%) Sulfonyl Toluene Disodium Amino Acid Sulfonate Sodium Methone Ethyl Ketone Dimethyl I Acid 4 Acid Methyl Ethyl Benzoate I Fatty Benzene Tetrayl Ester Based Fatty Oleyl Rape Amino Hydroxyphenoxy Oxylinoleic Acid Hydroxylargine Dicarboxylic Acid I Acid Methylstearic Acid Olive Pyrol Koji 2 Salicylic Hydrocarbon Plastic Hard Oil......... 0 12 3 4 12345678911111

ooooooooooool 0140000000200 量 1001250510050 適 1X IXooooooooooool 0140000000200 quantity 1001250510050 suitable for 1X IX

Hu I L 1- tv-i ^ l m^— ^—B^— ^^^^1 ^m tm ^^^^1 mu ^in —^m ml n^i (請先閱讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3. 10,000 23 307682_五、發明説明(21 ) 〔處方例8〕 熱敷劑 % 量 重 油烯胺 甘乙醯 酸氧醇 ί甘甲聚乙 糖苯酸二 果基脂酸 酸胺硬脂 麴對異硬 ο 5 匕曰 油 麻 箆 化 酸 烯 丙 聚 2 ο ο ο ο ο ο ο ο 物} 取物納 萃取二 醇萃酸 乙水乙納 丨{ 四酸 精精胺烯 草苓二丙 甘黃乙聚 0 5 5 1 ο ο ο ο (請先閱讀背面之注意事項再填寫本頁) 鋁油鈦水 化甘化製 氯濃氧精 2 適 ο ο ο 3 0 0 量 訂Hu IL 1- tv-i ^ lm ^ — ^ —B ^ — ^^^^ 1 ^ m tm ^^^^ 1 mu ^ in — ^ m ml n ^ i (Please read the notes on the back before filling in this Page) The paper standard printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs conforms to the Chinese National Standard (CNS) A4 specification (210X297 mm) 83. 3. 10,000 23 307682_ V. Description of invention (21) [Prescription Example 8] Hot compress Agent% amount of heavy oil enamine glycine oxyalcohol glyceryl methyl ethyl benzoate diacyl fatty acid amine stearic acid to the different hardness ο 5 dagger said linseed acid allylic poly 2 ο ο ο ο ο ο ο ο 物} Extraction of diol extract acid dihydrate ethyl sodium 丨 {tetraspermine spermine dipropylene dipropylene yellow ethylene 0 5 5 1 ο ο ο ο (please read the notes on the back before filling this page) Chlorine-concentrated oxygen concentrate made from aluminum oil titanium hydration and glycation 2 suitable ο ο ο 3 0 0

線J--S 經濟部中央標準局員工消費合作社印製 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐) 83. 3. 10,000 307682 A7 ____B7五、發明説明(22 ) 〔處方例9〕 香精 重量% 經濟部中央標準局員工消費合作社印製 1 ·麴酸 2 .尿刊酸 3. 2_乙基對甲氧基肉桂酸己酯 4 .流動異構鏈烷烴 5. 二棕櫚基磷脂醯膽鹸 6. 椰子油脂肪酸-乙酸醯胺 7 ·硬脂酸 8 .亞麻酸 9 ·酪梨油 1 〇 · g油 1 1 .天然維他命E 1 2 .對羥基苯甲酸酯 1 3 . 1 %羥基乙烯聚合物水溶液 14. 漢生膠 15. 乙二胺四乙酸二鈉 1 6 ·精製水 上述處方例1〜9均被確認係爲具有如表 揭示數據可滿足本發明目的效果之製劑。 適量 1及表2所 〔發明之效果〕 依本發明時可提供在含有麴酸及/或 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐) 83. 3.10,000 ——Ί3----i丨I (請先閱讀背面之注意事項再填寫本買) 訂 線< * 25 - 3〇7682 A7 ___B7_ 五、發明説明(23) 線吸收劑之外用劑中藉由添加至少一種選自烴類,脂質類 及硬化或未硬化油脂類所成群之皮虜外用劑,該外用劑係 且 , 而佳 ,極 劑亦 製性。 之定劑 定安製 安之之 極後效 亦久藥 久經其 客一 i 經,揮 ,解發 出分續 析,持 之色期 劑著長 收之以 吸類可 線酸爲 外麴還 紫善, 有改外 會以此 不可除 I---ir 1 ----^------訂------線、 (請先閲讀背面之注意事項再填寫本頁) 經濟部中央標準局員工消費合作社印製 83.3.10,000 本紙張尺度適用中國國家標準(CNS ) A4規格(210X297公釐)Line J--S The paper standard printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs is applicable to the Chinese National Standard (CNS) Α4 specification (210Χ297 mm) 83. 3. 10,000 307682 A7 ____B7 V. Description of the invention (22) [prescription example 9〕 Percentage of fragrances. Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 1. Ascorbic acid 2. Uric acid 3. 2-ethylhexyl p-methoxycinnamate 4. Flowing isoparaffin 5. Dipalmityl Phospholipid cholesterin 6. Coconut oil fatty acid-acetamide acetate 7. Stearic acid 8. Linolenic acid 9. Avocado oil 1 〇. G oil 1 1. Natural vitamin E 1 2. Paraben 1 3. 1% hydroxyethylene polymer aqueous solution 14. Xanthan gum 15. Disodium ethylenediaminetetraacetic acid 1 6 · Purified water The above-mentioned prescription examples 1 to 9 are all confirmed to be preparations with the data disclosed in the table that can satisfy the object of the present invention. Appropriate amount 1 and Table 2 [Effects of the invention] According to the present invention, it can be provided that the Chinese national standard (CNS) A4 specification (210X297 mm) is applicable to the standards containing kojic acid and / or the paper. 83. 3.10,000 ——Ί3- --- i 丨 I (Please read the precautions on the back before filling in the purchase) Threading < * 25-3〇7682 A7 ___B7_ V. Description of the invention (23) Adding at least one of the external agents for thread absorbent It is selected from the group consisting of hydrocarbons, lipids, and hardened or unhardened oils and fats. The external preparation is a skin-care agent, which is, more preferably, extremely effective. The fixation of Dingan is extremely effective after a long period of time. The medicine will be used for a long time, and the solution will be analyzed separately. , There is a change that will not be removed I --- ir 1 ---- ^ ------ order ------ line, (please read the precautions on the back before filling this page) Ministry of Economic Affairs Printed by the Central Bureau of Standards' Staff Consumer Cooperative 83.3.10,000 This paper standard applies to China National Standard (CNS) A4 (210X297mm)

Claims (1)

Α8 Β8 C8 D8Α8 Β8 C8 D8 々、申請專利範圍 第83 103796號申請專利案 中文申請專利範圍修正本 民國86年4月修正 1 . 一種安定化皮Λ外用轚療組成物,其係含有 0.1〜5重量%之麴酸及/或其衍生物與0.1〜5重 量%之紫外線吸收劑的皮虜外用S療組成物中,其特徵爲 添加0. 1〜10重量%之至少一種選自由①碳數10以 上之鏈烷烴系類或鏈烯烴系烴類:②選自由磷脂醯膽鹸, 大豆磷脂質,二棕櫚醯基磷脂醯膽鹸,神經醯胺,磷脂醯 肌醇,磷脂醢乙醇胺,神經鞘磷脂所成群之磷脂質類:③ 選自由聚合度爲4 0〜1 0 0之聚氧乙烯硬化箆麻油,三 異硬脂酸聚氧乙烯硬化箆麻油,異硬脂酸聚氧乙烯硬化箆 麻油,月桂酸聚氧乙烯硬化箆麻油,聚氧乙烯硬化箆麻油 ,聚氧乙烯山梨糖醇蜜蠟所成群之油脂類。 (請先閲讀背面之注意事項再填寫本頁) 裝. 訂 Λ 經濟部中央標準局員工消費合作社印褽 本紙張尺度適用中國國家標準(CNS ) Α4規格(210Χ297公釐)々, Patent Application No. 83 103796, Chinese Patent Application, Amendment of Patent Scope Amended in April 1986 1. A stabilizing skin Λ external treatment composition containing 0.1% to 5% by weight of kojic acid and / 1 ~ 10% by weight of at least one selected from the group consisting of paraffinic hydrocarbons with carbon number of 10 or more Or alkene-based hydrocarbons: ② selected from phospholipids grouped by phospholipid choline, soybean phospholipid, dipalmitoyl phosphatidyl phosphatidyl choline, ceramide, phosphatidylinositol, phosphatidylethanolamine, and sphingomyelin. Class: ③ selected from polyoxyethylene hardened hemp oil with a polymerization degree of 40 to 100, triisostearic acid polyoxyethylene hardened hemp oil, isostearic polyoxyethylene hardened hemp oil, lauric acid polyoxyethylene Oils grouped by hardened hemp oil, polyoxyethylene hardened hemp oil, and polyoxyethylene sorbitol beeswax. (Please read the precautions on the back before filling in this page) Pack. Order Λ Printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. The paper size is applicable to China National Standard (CNS) Α4 specification (210Χ297 mm)
TW083103796A 1993-10-28 1994-04-27 TW307682B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP27097193A JP3656197B2 (en) 1993-10-28 1993-10-28 Topical skin preparation

Publications (1)

Publication Number Publication Date
TW307682B true TW307682B (en) 1997-06-11

Family

ID=17493588

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083103796A TW307682B (en) 1993-10-28 1994-04-27

Country Status (5)

Country Link
JP (1) JP3656197B2 (en)
KR (1) KR100309400B1 (en)
CN (1) CN1092516C (en)
MY (1) MY125705A (en)
TW (1) TW307682B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4671205B2 (en) * 1999-10-25 2011-04-13 三省製薬株式会社 Skin preparation
JP4722683B2 (en) * 2005-12-02 2011-07-13 株式会社マンダム Emulsion composition for skin
JP5264065B2 (en) * 2006-09-22 2013-08-14 株式会社マンダム Emulsion composition for skin
JP5774029B2 (en) * 2010-02-22 2015-09-02 ロレアル Cosmetic composition
JP7290980B2 (en) * 2019-03-29 2023-06-14 株式会社コーセー Oil-in-water emulsified cosmetic

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0196109A (en) * 1987-10-06 1989-04-14 Lion Corp Skin-beautifying cosmetic
JP2822093B2 (en) * 1990-05-10 1998-11-05 株式会社コーセー W / O / W type emulsified cosmetic

Also Published As

Publication number Publication date
KR100309400B1 (en) 2002-02-28
MY125705A (en) 2006-08-30
JP3656197B2 (en) 2005-06-08
KR950010876A (en) 1995-05-15
CN1106658A (en) 1995-08-16
JPH07126122A (en) 1995-05-16
CN1092516C (en) 2002-10-16

Similar Documents

Publication Publication Date Title
DE60016670T2 (en) Cosmetic compositions containing at least one hydroxystilbene and ascorbic acid
TW307683B (en)
RU2418575C2 (en) Nanoliposome with application of etherificated lecitin and method of obtaining such, as well as composition for prevention or treatment of skin diseases including such liposomes
US6168798B1 (en) Non-irritating composition for treating acne and other skin conditions
US20100168468A1 (en) Wrinkle-preventing and improving composition
US5637293A (en) Preparation for epidermis
BRPI0914843A2 (en) COSMETIC COMPOSITION, AND, METHOD FOR WHITENING SKIN COLOR
AU9742501A (en) Method for reducing the appearance of dark circles under the eyes
EP0084341B2 (en) Emulsion-type composition for external use
JP4398641B2 (en) Hypoallergenic and non-irritating skin care preparations
TW307682B (en)
WO1998031338A1 (en) Compositions promoting collagen production
JPS6115809A (en) Cell activator
JP3657068B2 (en) Anti-photoaging agent and external preparation for skin
TW202308591A (en) Cosmetic
KR20080059820A (en) A anti-wrinkle agent containing camellia japonica oil
JP4188150B2 (en) Skin preparation
JP2781982B2 (en) External preparation for skin
JP4488933B2 (en) Wrinkle improving agent and external composition for skin
RO107544B1 (en) Cosmetic cream
JP2000007548A (en) Skin lotion
JP3488479B2 (en) Bath composition
KR20170107128A (en) Manufacturing method of multi-lamellar structured transparent liquid crystal composition
JPS63211208A (en) Cosmetic
JP2001508789A (en) Cosmetic or dermatological products compatible with skin ecology

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent